<?xml version="1.0" encoding="UTF-8"?>
<p>The growing interest in developing a universal influenza vaccine has led to the need for alternative serological assays that are able to detect different classes of antibodies, such as anti-stalk, anti-NA, and secretory immunoglobulin A (s-IgA) ones [
 <xref rid="B24-vaccines-08-00043" ref-type="bibr">24</xref>]. Stalk-specific antibodies can be detected mainly by enzyme-linked immunosorbent assays (ELISAs) by using purified chimeric (cHA) proteins, such as cH6/1 (which contains an H6 head domain from A/mallard/Sweden/81/02 combined with an H1 stalk domain of A/California/04/09) [
 <xref rid="B25-vaccines-08-00043" ref-type="bibr">25</xref>].
</p>
